anti-cancer drug
Scope
Date
~
-
Bio & Pharma
Gencurix supplies companion diagnostic kits to cancer center in India
South Korean biotech company Gencurix Inc. on Friday said it started supplying its companion diagnostic test Droplex to a national cancer center in ...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm to export epilepsy drug tech to Middle Eastern firm
South Korea's SK Biopharmaceuticals announced on Friday a strategic tie-up with Hikma MENA FZE, marking the introduction of its new epilepsy medicat...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals forms Scientific Advisory Board
South Korea's SK Biopharmaceuticals assembled its Scientific Advisory Board (SAB) composed of world-renowned physicians and drug development experts...
Aug 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Gencurix joins US gov't Cancer Moonshot project
South Korean cancer molecular diagnostics company Gencurix Inc. announced on Monday that it joins US President Joe Biden's cancer-conquering project...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit to supply AI diagnosis solution to Saudi's medical institution
South Korea's medical AI company Lunit announced on Wednesday that it has signed a contract to supply its artificial intelligence (AI) solution for ...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Kwangdong to sell exclusively three global rare disease drugs
South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it signed an agreement for securing exclusive sales and distri...
Jul 24, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's NGeneBio establishes US corporation NGeneBioAI
South Korean medical diagnostic company NGeneBio Co. announced on Monday that it has established an artificial intelligence (AI) precision diagnosti...
Jul 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Clinomics releases equipment that quickly finds lung cancer mutations
Clinomics, a South Korean biotech company specializing in liquid biopsies, on Thursday said it developed equipment that can detect four types of l...
Jul 21, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals to supply diabetes drugs to AstraZeneca Korea
SK Chemicals Co., a South Korean chemicals maker and drug developer, said on Thursday it has signed a contract to supply diabetes medications to glo...
Jul 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Novomics expands presence in Chinese cancer market
South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm eyes Asia's No.1 spot in radioactive drug market
South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma participates in US gov’t Cancer Moonshot
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...
Jul 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada
South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...
Jul 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Novartis $391 mn deal powers Samsung Biologics backlogs to record high
Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...
Jul 10, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N releases new drug for GERD in Indonesia
South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...
Jul 10, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SCM Lifescience kicks off anti-hair loss product exports to SE Asia
South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Syntekabio expands to US with local CRO
South Korean artificial intelligence (AI) drugmaker Syntekabio Inc. has partnered up with a US clinical research organization (CRO) to enter the wor...
Jun 20, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals, AZ mark first commercial production of diabetes drugs
South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...
Jun 19, 2023 (Gmt+09:00)
-
Petrochemicals
LG Chem to sell $1.6 bn stake in LG Energy to foreign investors
South Korea’s leading chemicals company LG Chem Ltd. is slated to secure about 2 trillion won ($1.6 billion) by selling a minority stake in it...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Huons’ 2% lidocaine gets approval from FDA
South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand